SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001140361-12-003236
Filing Date
2012-01-20
Accepted
2012-01-20 16:24:44
Documents
2
Group Members
ACM CAPITAL PARTNERS, LLCJAY VENKATESAN

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G 95183
2 MISCELLANEOUS EXHIBITS misc1.htm EX-1.1 11238
  Complete submission text file 0001140361-12-003236.txt   108307
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Subject) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59139 | Film No.: 12537264
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 CALIFORNIA, SUITE 600 SAN FRANCISCO CA 94111
Business Address 230 CALIFORNIA, SUITE 600 SAN FRANCISCO CA 94111 4158744800
Ayer Capital Management, LP (Filed by) CIK: 0001471149 (see all company filings)

IRS No.: 262134101 | State of Incorp.: DE | Fiscal Year End: 1209
Type: SC 13G